Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M M Balk

Showing results (51-60 of 62) with videos related to

Pageof 7
Sort By:
Transplant Immunology|December 14, 2004
Intragraft heme oxygenase-1 and coronary artery disease after heart transplantationCecile T J Holweg, Aggie H M M Balk, Jasper Snaathorst, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 25, 2012
Clinical implications of chronic hepatitis E virus infection in heart transplant recipientsLudi Koning, Suzan D Pas, Robert A de Man, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 5, 2009
[Heart transplantation in children. 10 years of experience in the Erasmus MC in Rotterdam, the Netherlands]Michiel Dalinghaus, Aggie H M M Balk, Matthijs de Hoog, et al.
Transplantation|June 5, 2003
Anti-CD25 monoclonal antibody therapy affects the death signals of graft-infiltrating cells after clinical heart transplantationC C Baan, A H M M Balk, I C van Riemsdijk, et al.
Clinical Pharmacology and Therapeutics|December 14, 2004
Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genesDennis A Hesselink, Teun van Gelder, Ron H N van Schaik, et al.
Transplantation|June 15, 2007
Interleukin-21: an interleukin-2 dependent player in rejection processesCarla C Baan, Aggie H M M Balk, I Esmé Dijke, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Heart transplantation in the Netherlands: quo vadis?J H Kirkels, N de Jonge, C Klöpping, et al.
Emerging Infectious Diseases|April 21, 2012
Hepatitis E virus infection among solid organ transplant recipients, the NetherlandsSuzan D Pas, Rob A de Man, Claudia Mulders, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 4, 2008
Donor-derived mesenchymal stem cells remain present and functional in the transplanted human heartM J Hoogduijn, M J Crop, A M A Peeters, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 28, 2010
Recurrent and founder mutations in the Netherlands: mutation p.K217del in troponin T2, causing dilated cardiomyopathyE Otten, R H Lekanne Dit Deprez, M M Weiss, et al.
Pageof 7

Showing results (51-60 of 62) with videos related to

Sort By:
Pageof 7
Transplant Immunology|December 14, 2004
Intragraft heme oxygenase-1 and coronary artery disease after heart transplantationCecile T J Holweg, Aggie H M M Balk, Jasper Snaathorst, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|December 25, 2012
Clinical implications of chronic hepatitis E virus infection in heart transplant recipientsLudi Koning, Suzan D Pas, Robert A de Man, et al.
Nederlands Tijdschrift Voor Geneeskunde|March 5, 2009
[Heart transplantation in children. 10 years of experience in the Erasmus MC in Rotterdam, the Netherlands]Michiel Dalinghaus, Aggie H M M Balk, Matthijs de Hoog, et al.
Transplantation|June 5, 2003
Anti-CD25 monoclonal antibody therapy affects the death signals of graft-infiltrating cells after clinical heart transplantationC C Baan, A H M M Balk, I C van Riemsdijk, et al.
Clinical Pharmacology and Therapeutics|December 14, 2004
Population pharmacokinetics of cyclosporine in kidney and heart transplant recipients and the influence of ethnicity and genetic polymorphisms in the MDR-1, CYP3A4, and CYP3A5 genesDennis A Hesselink, Teun van Gelder, Ron H N van Schaik, et al.
Transplantation|June 15, 2007
Interleukin-21: an interleukin-2 dependent player in rejection processesCarla C Baan, Aggie H M M Balk, I Esmé Dijke, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|February 20, 2015
Heart transplantation in the Netherlands: quo vadis?J H Kirkels, N de Jonge, C Klöpping, et al.
Emerging Infectious Diseases|April 21, 2012
Hepatitis E virus infection among solid organ transplant recipients, the NetherlandsSuzan D Pas, Rob A de Man, Claudia Mulders, et al.
American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons|November 4, 2008
Donor-derived mesenchymal stem cells remain present and functional in the transplanted human heartM J Hoogduijn, M J Crop, A M A Peeters, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|October 28, 2010
Recurrent and founder mutations in the Netherlands: mutation p.K217del in troponin T2, causing dilated cardiomyopathyE Otten, R H Lekanne Dit Deprez, M M Weiss, et al.
Pageof 7